Literature DB >> 1902797

Measles, killer of millions in developing countries: strategy for rapid elimination and continuing control.

A B Sabin.   

Abstract

Measles, which is still killing about two million children a year in poor countries, was mostly eliminated within two to three months after the conclusion of a special, national mass vaccination campaign in which all children of a selected age group received measles vaccine subcutaneously during a period of days to months, regardless of a history of previous vaccination or measles. This strategy was tested in the Dominican Republic in 1985, in Cuba in 1986-87, and in the State of São Paulo, Brazil May 11-June 10, 1987. Subsequent control was maintained by different procedures in the three states. A simple, rapid indirect immunofluorescent test for IgM measles antibody, used in Greater São Paulo, was more efficient in confirming concurrent infection with measles virus than the hemagglutination inhibition test for IgG antibody, and only one blood specimen taken during the course of the rash was needed to confirm the etiologic diagnosis in 97.5% of 240 cases confirmed by IgM. In Greater São Paulo and Cuba, it was found that over 90% of the small number of suspect measles cases reported during the first year after the mass campaign, were not caused by measles virus. The cost of disposable syringes and needles in the State of São Paulo, where 8,565,230 children were vaccinated in 10,527 centers in 30 days, was U.S. $2,057,753 or 63% of the total. Immunization by aerosol could have vaccinated this number of children more easily and effectively in one day if each of the vaccination centers had been supplied with one plastic foot or hand pressure pump and nebulizer at a cost of only about U.S. $300,000.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1902797     DOI: 10.1007/bf00221337

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  19 in total

1.  International Task Force for Disease Eradication.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1990-04-06       Impact factor: 17.586

2.  Measles--Hungary.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1989-10-06       Impact factor: 17.586

3.  [Interference between measles and poliomyelitis vaccines].

Authors:  C S Pannuti; V A de Souza; N Takaoka; S T da Silva Leme; C R Pereira; R P de Souza Carvalho; V Amato Neto
Journal:  Bol Oficina Sanit Panam       Date:  1987-09

4.  Stability on storage at various temperatures of live measles, mumps and rubella virus vaccines in new stabilizer.

Authors:  W J McAleer; H Z Markus; A A McLean; E B Buynak; M R Hilleman
Journal:  J Biol Stand       Date:  1980

5.  Specific immunoglobulin M enzyme-linked immunosorbent assay for confirming the diagnosis of measles.

Authors:  A W Lievens; P A Brunell
Journal:  J Clin Microbiol       Date:  1986-09       Impact factor: 5.948

6.  Elimination of indigenous measles from the United States.

Authors:  A R Hinman; C D Kirby; D L Eddins; W A Orenstein; R H Bernier; P M Turner; K J Bart
Journal:  Rev Infect Dis       Date:  1983 May-Jun

7.  High effectiveness of aerosolized chick embryo fibroblast measles vaccine in seven-month-old and older infants.

Authors:  A B Sabin; P Albrecht; A K Takeda; E M Ribeiro; R Veronesi
Journal:  J Infect Dis       Date:  1985-12       Impact factor: 5.226

8.  Measles mortality and vaccine efficacy in rural West Africa.

Authors:  H F Hull; P J Williams; F Oldfield
Journal:  Lancet       Date:  1983-04-30       Impact factor: 79.321

9.  Strategies for elimination of poliomyelitis in different parts of the world with use of oral poliovirus vaccine.

Authors:  A B Sabin
Journal:  Rev Infect Dis       Date:  1984 May-Jun

10.  Cuba: mass polio vaccination program, 1962-1982.

Authors:  R Rodríguez Cruz
Journal:  Rev Infect Dis       Date:  1984 May-Jun
View more
  6 in total

1.  Successful respiratory immunization with dry powder live-attenuated measles virus vaccine in rhesus macaques.

Authors:  Wen-Hsuan Lin; Diane E Griffin; Paul A Rota; Mark Papania; Stephen P Cape; David Bennett; Brian Quinn; Robert E Sievers; Charles Shermer; Kenneth Powell; Robert J Adams; Steven Godin; Scott Winston
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-31       Impact factor: 11.205

Review 2.  Perspectives on rapid elimination and ultimate global eradication of paralytic poliomyelitis caused by polioviruses.

Authors:  A B Sabin
Journal:  Eur J Epidemiol       Date:  1991-03       Impact factor: 8.082

3.  Measles control in Maputo, Mozambique, using a single dose of Schwarz vaccine at age 9 months.

Authors:  F T Cutts; O Monteiro; P Tabard; J Cliff
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

4.  Dot immunobinding assay for simultaneous detection of specific immunoglobulin G antibodies to measles virus, mumps virus, and rubella virus.

Authors:  F Condorelli; T Ziegler
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

5.  Ex vivo analysis of cytotoxic T lymphocytes to measles antigens during infection and after vaccination in Gambian children.

Authors:  A Jaye; A F Magnusen; A D Sadiq; T Corrah; H C Whittle
Journal:  J Clin Invest       Date:  1998-12-01       Impact factor: 14.808

6.  Disease control of delay SEIR model with nonlinear incidence rate and vertical transmission.

Authors:  Yan Cheng; Qiuhui Pan; Mingfeng He
Journal:  Comput Math Methods Med       Date:  2013-12-12       Impact factor: 2.238

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.